Cargando…
Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
Often, pathological Gleason Score (GS) and stage of prostate cancer (PCa) were inconsistent with biopsy GS and clinical stage. However, there were no widely accepted methods predicting upgrading and upstaging PCa. In our study, we investigated the association between serum testosterone and upgrading...
Autores principales: | Gao, Yuan, Jiang, Chen-Yi, Mao, Shi-Kui, Cui, Di, Hao, Kui-Yuan, Zhao, Wei, Jiang, Qi, Ruan, Yuan, Xia, Shu-Jie, Han, Bang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955193/ https://www.ncbi.nlm.nih.gov/pubmed/26732103 http://dx.doi.org/10.4103/1008-682X.169984 |
Ejemplares similares
-
Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019) -
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016) -
Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy
por: Huang, Cong, et al.
Publicado: (2023) -
Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019) -
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)